(Q36288888)

13 August 2017

1 reference

title

Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects (English)

1 reference

13 August 2017

Papapetrou EP

1

1 reference

13 August 2017

Zoumbos NC

series ordinal

2

1 reference

13 August 2017

Athanassiadou A

series ordinal

3

1 reference

13 August 2017

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

12 Suppl 1

1 reference

13 August 2017

page(s)

S118-30

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302626

13 August 2017

exact match

0 references

cites work

Gene therapy using hematopoietic stem cells: Sisyphus approaches the crest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Diversification of haematopoietic stem cells to specific lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene transfer and the treatment of haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene therapy for genetic haematological disorders and immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene therapy for inherited disorders of haematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Therapeutic applications for hematopoietic stem cell gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Prospects and implications of using chromatin insulators in gene therapy and transgenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Progress toward vector design for hematopoietic stem cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Side effects of retroviral gene transfer into hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Improvements in gene therapy: averting the immune response to adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Repeat-induced gene silencing in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Integration of foreign DNA and its consequences in mammalian systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Expansions of transgene repeats cause heterochromatin formation and gene silencing in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Cosuppression comes to the animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Nonviral approaches satisfying various requirements for effective in vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene therapy progress and prospects: nonviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Emerging applications of gene transfer in the hematopoietic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Cellular and molecular barriers to gene transfer by a cationic lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

An efficient gene transfer system for hematopoietic cell line using transient and stable vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Cationic lipids in gene delivery: principles, vector design and therapeutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Increased liposome-mediated gene transfer into haematopoietic cells grown in adhesion to stromal or fibroblast cell line monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Transgene expression, but not gene delivery, is improved by adhesion-assisted lipofection of hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Transgene expression kinetics after transfection with cationic phosphonolipids in hematopoietic non adherent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Successful biolistic transformation of mouse pancreatic islets while preserving cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Transient transfection of primary T helper cells by particle-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Cytokine transgene expression and promoter usage in primary CD34+ cells using particle-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Molecular Basis for Cell Membrane Electroporationa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Electrically induced DNA uptake by cells is a fast process involving DNA electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene transfer into human leukemia cell lines by electroporation: experience with exponentially decaying and square wave pulse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Transient RNA interference in hematopoietic progenitors with functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

The effect of cell synchronization on the efficiency of stable gene transfer by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene therapy in transplantation: pathological consequences of unavoidable plasmid contamination with lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Voltage-induced pore formation and hemolysis of human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Improving electrotransfection efficiency by post-pulse centrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Formation and resealing of pores of controlled sizes in human erythrocyte membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce cell cycle progression through the synthesis of c-Myc protein by internal ribosome entry site-mediated translation via phosphatidylinositol 3-kinase pathway in human factor-de

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Caspase-3 has a nonapoptotic function in erythroid maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

The effect of cell division on the cellular dynamics of microinjected DNA and dextran

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Anatomy of highly expressing chromosomal sites targeted by retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Transcriptional properties of genomic transgene integration sites marked by electroporation or retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Chromosome-based vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Episomal vectors for gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Isolation of human sequences that replicate autonomously in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

The potential of extrachromosomal replicating vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Safety-modified episomal vectors for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Epstein-Barr virus vectors for gene expression and transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

LCR-mediated, long-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

A reporter system using a flow cytometer to detect promoter/enhancer activity in lymphoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Human artificial episomal chromosomes for cloning large DNA fragments in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Stable episomal maintenance of yeast artificial chromosomes in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT−) using an Epstein - Barr virus-derived cDNA expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Epstein-Barr virus-based vectors that replicate in rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Chromosome engineering: prospects for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Strategies for engineering human chromosomes with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Formation of de novo centromeres and construction of first-generation human artificial microchromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Stable gene expression from a mammalian artificial chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Functional complementation of a genetic deficiency with human artificial chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Functional human CFTR produced by a stable minichromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Biological significance of unwinding capability of nuclear matrix-associating DNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

An episomal mammalian replicon: sequence-independent binding of the origin recognition complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

The role of the nuclear pore complex in adenovirus DNA entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

In vivo correction of murine tyrosinemia type I by DNA-mediated transposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Stable nonviral genetic correction of inherited human skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Time course of gene expression after plasmid DNA gene transfer to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Optimization of plasmid vectors for high-level expression in lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

A new DNA vehicle for nonviral gene delivery: supercoiled minicircle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Lymphocyte apoptosis: induction by gene transfer techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Animal-free production of ccc-supercoiled plasmids for research and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

Murine leukemia induced by retroviral gene marking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

In vivo electrically mediated protein and gene transfer in murine melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Gene transfer into mouse lyoma cells by electroporation in high electric fields

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Gene introduction into granulocyte-macrophage progenitor cells by electroporation: the relationship between introduction efficiency and the proportion of cells in S-phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

High-efficiency electrotransfection of human primary hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Apoptosis induced by DNA uptake limits transfection efficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Electric field pulses can induce apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Gene transfection of mouse primordial germ cells in vitro and analysis of their survival and growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Association of a host DNA structure with retroviral integration sites in chromosomal DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Plasmid maintenance of derivatives of oriP of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Increased expression of DNA cointroduced with nuclear protein in adult rat liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Site-specific genomic integration produces therapeutic Factor IX levels in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

CpG: the double-edged sword

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Contribution of Plasmid DNA to Inflammation in the Lung after Administration of Cationic Lipid:pDNA Complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302626

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302626

1 reference

release_qq4fzprgu5bmzpyjzmyzhqofcu

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qq4fzprgu5bmzpyjzmyzhqofcu

24 November 2022

mapped directly with Wikidata item

1 reference